These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 8702226

  • 21. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F, Cesana G, Caprotti R, Bovo G, Uggeri F, Piacentini MG, Crippa S, Uggeri F.
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [Abstract] [Full Text] [Related]

  • 22. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC, Conway TF, Sabel MS, Jong YS, Mathiowitz E, Bankert RB, Egilmez NK.
    Cancer Res; 2002 Dec 15; 62(24):7254-63. PubMed ID: 12499267
    [Abstract] [Full Text] [Related]

  • 23. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.
    Dobrzanski MJ, Reome JB, Hylind JC, Rewers-Felkins KA, Abdulsamad K, Adams SL.
    Immunol Invest; 2008 Dec 15; 37(4):315-38. PubMed ID: 18569073
    [Abstract] [Full Text] [Related]

  • 24. Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting.
    Ampollini L, Soltermann A, Felley-Bosco E, Lardinois D, Arni S, Speck RF, Weder W, Opitz I.
    Eur J Cardiothorac Surg; 2009 Mar 15; 35(3):457-62. PubMed ID: 19162494
    [Abstract] [Full Text] [Related]

  • 25. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K, Saio M, Suwa T, Frey AB, Umemura N, Imai H, Ouyang GF, Osada S, Balazs M, Adany R, Kawaguchi Y, Yoshida K, Takami T.
    J Leukoc Biol; 2008 Sep 15; 84(3):679-88. PubMed ID: 18566103
    [Abstract] [Full Text] [Related]

  • 26. Alterations of tumour cells, stroma and apoptosis in rat prostatic adenocarcinoma following treatment with histamine, interleukin-2 and irradiation.
    Johansson S, Landström M, Henriksson R.
    Anticancer Res; 1999 Sep 15; 19(3A):1961-9. PubMed ID: 10470141
    [Abstract] [Full Text] [Related]

  • 27. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM, Okada H, Brissette-Storkus CS, Villa LA, Attanucci J, Lotze MT, Pollack IF, Bozik ME, Chambers WH.
    Cancer Res; 2000 May 01; 60(9):2449-57. PubMed ID: 10811123
    [Abstract] [Full Text] [Related]

  • 28. Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
    Indrová M, Bieblová J, Jandlová T, Vonka V, Pajtasz-Piasecka E, Reinis M.
    Int J Oncol; 2006 Jan 01; 28(1):253-9. PubMed ID: 16328003
    [Abstract] [Full Text] [Related]

  • 29. Interleukin generation in experimental colon cancer of rats: effects of tumor growth and tumor therapy.
    Ravikumar T, Rodrick M, Steele G, Marrazo J, O'Dwyer P, Dodson T, King V.
    J Natl Cancer Inst; 1985 Apr 01; 74(4):893-8. PubMed ID: 3872959
    [Abstract] [Full Text] [Related]

  • 30. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines.
    Rodolfo M, Zilocchi C, Melani C, Cappetti B, Arioli I, Parmiani G, Colombo MP.
    J Immunol; 1996 Dec 15; 157(12):5536-42. PubMed ID: 8955204
    [Abstract] [Full Text] [Related]

  • 31. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
    Iwadate Y, Yamaura A, Sato Y, Sakiyama S, Tagawa M.
    Cancer Res; 2001 Dec 15; 61(24):8769-74. PubMed ID: 11751397
    [Abstract] [Full Text] [Related]

  • 32. The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma.
    Salter J, Maclennan KA, Moore J, Dadian G, Riches PG, Gore ME.
    J Pathol; 1995 Jun 15; 176(2):167-73. PubMed ID: 7636627
    [Abstract] [Full Text] [Related]

  • 33. Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma.
    Serba S, Schmidt J, Wentzensen N, Ryschich E, Märten A.
    Gut; 2008 Mar 15; 57(3):344-51. PubMed ID: 17675324
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of cytokine toxicity induced by vaccinia virus-mediated IL-2 and IL-12 antitumour immunotherapy.
    Chen B, Timiryasova TM, Gridley DS, Andres ML, Dutta-Roy R, Fodor I.
    Cytokine; 2001 Sep 21; 15(6):305-14. PubMed ID: 11594797
    [Abstract] [Full Text] [Related]

  • 35. In vivo tumouricidal effect of T lymphocytes activated by liposomes containing adriamycin on chemically-induced rat malignant fibrous histiocytoma.
    Yakushiji T, Yonemura K, Nishida K, Takagi K.
    Anticancer Res; 1997 Sep 21; 17(6D):4347-54. PubMed ID: 9494532
    [Abstract] [Full Text] [Related]

  • 36. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J.
    Clin Cancer Res; 2003 May 21; 9(5):1837-49. PubMed ID: 12738742
    [Abstract] [Full Text] [Related]

  • 37. Immunohistochemical characterisation of the local immune response in azoxymethane-induced colon tumours in the BDIX inbred rat strain.
    Kobaek-Larsen M, Diederichsen A, Agger R, Nissen I, Hokland M, Zeuthen J, Ritskes-Hoitinga J.
    APMIS; 2004 Oct 21; 112(10):698-707. PubMed ID: 15601321
    [Abstract] [Full Text] [Related]

  • 38. HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy.
    Indrová M, Bieblová J, Rossowska J, Kuropka P, Pajtasz-Piasecka E, Bubeník J, Reinis M.
    Int J Oncol; 2009 Jan 21; 34(1):173-9. PubMed ID: 19082488
    [Abstract] [Full Text] [Related]

  • 39. Chemoimmunotherapy of murine mammary adenocarcinomas.
    Ames IH.
    Anticancer Res; 2004 Jan 21; 24(4):2249-56. PubMed ID: 15330169
    [Abstract] [Full Text] [Related]

  • 40. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
    Chang CY, Lee J, Kim EY, Park HJ, Kwon CH, Joh JW, Kim SJ.
    BMC Cancer; 2007 May 23; 7():87. PubMed ID: 17519043
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.